Can Epclusa (sofosbuvir/velpatasvir) be taken with antacids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epclusa with Antacids

Epclusa (sofosbuvir/velpatasvir) can be taken with antacids, but you must separate the administration by 4 hours to avoid reduced velpatasvir absorption and potential treatment failure. 1

Key Administration Guidelines

Antacids (aluminum/magnesium hydroxide)

  • Separate by 4 hours from Epclusa administration 1
  • This is a firm requirement, not a suggestion
  • Velpatasvir solubility decreases as gastric pH increases, leading to reduced drug concentrations

H2-Receptor Antagonists (e.g., famotidine)

  • May be given simultaneously with Epclusa OR separated by 12 hours 1
  • Maximum dose: equivalent to famotidine 40 mg twice daily
  • More flexible timing than antacids

Proton-Pump Inhibitors (e.g., omeprazole)

  • Coadministration is NOT recommended 1
  • If medically necessary:
    • Take Epclusa with food
    • Give Epclusa 4 hours before omeprazole 20 mg
    • Limited to omeprazole 20 mg only; other PPIs not studied
  • A recent case report suggests co-administration with soda may overcome this interaction 2, but this is not yet standard practice

Clinical Rationale

The interaction occurs because velpatasvir is a pH-dependent drug—its absorption decreases significantly in higher pH environments. Acid-reducing agents raise gastric pH, potentially leading to:

  • Subtherapeutic velpatasvir levels
  • Treatment failure
  • Development of resistance-associated substitutions

The FDA label explicitly addresses this based on pharmacokinetic studies showing decreased velpatasvir concentrations with acid-reducing agents 1.

Common Pitfalls to Avoid

  • Don't assume all acid reducers are the same: Antacids require 4-hour separation, H2-blockers are more flexible, and PPIs should generally be avoided
  • Don't forget food with PPIs: If you must use a PPI, Epclusa must be taken with food for this specific scenario
  • Don't exceed recommended PPI doses: Only omeprazole 20 mg has been studied; higher doses or other PPIs lack safety data

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.